Full Length Research Paper
References
|
Asfaw A, Ali D, Eticha T, Alemayehu A, Alemayehu M, Kindeya F (2015). CD4 cell count trends after commencement of antiretroviral therapy among HIV-infected patients in Tigray, Northern Ethiopia: A retrospective cross-sectional study. PloS one 10(3):e0122583. Bennett KK, DeGruttola VG, Marschner IC, Havlir DV, Richman DD: Baseline predictors of CD4 T-lymphocyte recovery with combination antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 31(1):20-26. |
|
|
Berhe T, Melkamu Y, Amare A (2012). The pattern and predictors of mortality of HIV/AIDS patients with neurologic manifestation in Ethiopia: a retrospective study. AIDS Res. Ther. 9:11. |
|
|
Boulassel MR, Chomont N, Pai NP, Gilmore N, Sekaly RP, Routy JP (2012). CD4 T cell nadir independently predicts the magnitude of the HIV reservoir after prolonged suppressive antiretroviral therapy. J. Clin. Virol. 53(1):29-32. |
|
|
Calmy A, Balestre E, Bonnet F, Boulle A, Sprinz E, Wood R, Delaporte E, Messou E, McIntyre J, El Filali KM, Schechter M, Kumarasamy N, Bangsberg D, McPhail P, Van Der Borght S, Zala C, Egger M, Thiébaut R, Dabis F: Mean CD4 cell count changes in patients failing a first-line antiretroviral therapy in resource-limited settings. BMC Infect. Dis. 12:147. |
|
|
Evan W, Robert S, Benita Y, Richard H, Michael V, Julio S (2003). Is there a baseline CD4 cell count that precludes a survival response to modern antiretroviral therapy. AIDS 17:711-720. |
|
|
Federal Democratic Republic of Ethiopia (FDRE) (2014). National guidelines for comprehensive HIV prevention, care and treatment. Addis Ababa, Ethiopia: FMOH; 2014. Available at: |
|
|
Federal Ministry of Education (FMOE) (2008). Report on Progress towards Implementation of the UN Declaration of commitment on HIV/AIDS, Ethiopia. In: Edited by HAPCO. Addis Ababa. Available at: |
|
|
Florence E, Lundgren J, Dreezen C, Fisher M, Kirk O, Blaxhult Aea: Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study. HIV Med. 4(3):255-62. |
|
|
García F, de Lazzari E, Plana M, Castro P, Mestre G, Nomdedeu M, Fumero E, Martínez E, Mallolas J, Blanco JL, Miró JM, Pumarola T, Gallart T, Gatell JM (2004). Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count. J. Acquir. Immune Defic. Syndr. 36(2):702-713. |
|
|
Jerene D, Endale A, Hailu Y, Lindtjorn B (2006a). Predictors of early death in a cohort of Ethiopian patients treated with HAART. BMC infect. Dis. 6:136. |
|
|
Jerene D, Naess A, Lindtjorn B (2006b). Antiretroviral therapy at a district hospital in Ethiopia prevents death and tuberculosis in a cohort of HIV patients. AIDS Res. Ther. 3:10. |
|
|
Johansson KA, Jerene D, Norheim OF (2008). National HIV treatment guidelines in Tanzania and Ethiopia: are they legitimate rationing tools? J. Med. Ethics 34(6):478-483. |
|
|
Kanters S, Nachega J, Funk A, Mukasa B, Montaner JS, Ford N, Bucher HC, Mills EJ (2014). CD4(+) T-cell recovery after initiation of antiretroviral therapy in a resource-limited setting: a prospective cohort analysis. Antivir. Ther. 19(1):31-39. |
|
|
Kaufmann GR, Bloch M, Finlayson R, Zaunders J, Smith D, Cooper DA (2002). The extent of HIV-1-related immunodeficiency and age predict the long-term CD4 T lymphocyte response to potent antiretroviral therapy. AIDS 16(3):359-367. |
|
|
Kilaru K, Kumar A, Sippy N, Carter A, Roach T (2006). Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country. HIV Med. 7:99-104. |
|
|
Koethe JR, Jenkins CA, Lau B, Shepherd BE, Silverberg MJ, Brown TT, Blashill AJ, Anema A, Willig A, Stinnette S, Napravnik S, Gill J, Crane HM, Sterling TR (2015). Body mass index and early CD4 T-cell recovery among adults initiating antiretroviral therapy in North America, 1998-2010. HIV Med. 16(9):572-577. |
|
|
Lange CG, Valdez H, Medvik K, Asaad R, Lederman MM (2002). CD4+ T-lymphocyte nadir and the effect of highly active antiretroviral therapy on phenotypic and functional immune restoration in HIV-1 infection. Clin. Immunol. 102(2):154-161. |
|
|
Lawn SD, Myer L, bekker LG, Wood R (2006). CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa. BMC Infect. Dis. 6:59. |
|
|
Lederman HM, Williams PL, Wu JW, Evans TG, Cohn SE, McCutchan JA, Koletar SL, Hafner R, Connick E, Valentine FT, McElrath MJ, Roberts NJ Jr, Currier JS (2003). Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletion. J. Infect. Dis. 188(12):1794-1803. |
|
|
Lok JJ, Bosch RJ, Benson CA, Collier AC, Robbins GK, Shafer RW, Hughes MD (2010). Long-term increase in CD4+ T-cell counts during combination antiretroviral therapy for HIV-1 infection. AIDS 24(12):1867-1876. |
|
|
Luz PM, Grinsztejn B, Velasque L, Pacheco AG, Veloso VG, Moore RD, Struchiner CJ (2014). Long-term CD4+ cell count in response to combination antiretroviral therapy. PLoS One 9(4):e93039. |
|
|
McKinnon LR, Kimani M, Wachihi C, Nagelkerke NJ, Muriuki FK, Kariri A, Lester RT, Gelmon L, Ball TB, Plummer FA, Kaul R, Kimani J (2010). Effect of baseline HIV disease parameters on CD4+ T cell recovery after antiretroviral therapy initiation in Kenyan women. PLoS One 5(7):e11434. |
|
|
Ministry of Health (MoH) (2005). Health Sector Strategic Plan (HSDP-III) 2005/6-2009/10. Planning and Programming Department. . In. (Ed.) Ababa. |
|
|
Mutimura E, Addison D, Anastos K, Hoover D, Dusingize JC, Karenzi B, Izimukwiye I, Mutesa L, Nsanzimana S, Nash D (2015). Trends in and determinants of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda. AIDS 29(1):67-76. |
|
|
Naftalin CM, Wong NS, Chan DP, Wong KH, Reidpath DD, Lee SS (2015). Three different patterns of CD4 recovery in a cohort of Chinese HIV patients following antiretroviral therapy - a five-year observational study. Int. J. STD AIDS 26(11):803-809. |
|
|
Okulicz JF, Grandits GA, Weintrob AC, Landrum ML, Ganesan A, Crum-Cianflone NF, Agan BK, Marconi VC (2010). CD4 T cell count reconstitution in HIV controllers after highly active antiretroviral therapy. Clin. Infect. Dis. 50(8):1187-1191. |
|
|
Stephen D, Anthony D, Xavier A, Landon M, Robin W (2008). Early mortality among adults accessing antiretroviral treatment programs in sub-Saharan Africa. AIDS 22:1897-1908. |
|
|
Waters L, Fisher M, Anderson J, Wood C, Delpech V, Hill T, Walsh J, Orkin C, Bansi L, Gompels M, Phillips A, Johnson M, Gilson R, Easterbrook P, Leen C, Porter K, Gazzard B, Sabin C (2011). Responses to highly active antiretroviral therapy and clinical events in patients with a low CD4 cell count: late presenters vs. late starters. HIV Med. 12(5):289-298. |
|
|
Wright ST, Carr A, Woolley I, Giles M, Hoy J, Cooper DA, Law MG: CD4 cell responses to combination antiretroviral therapy in patients starting therapy at high CD4 cell counts. J. Acquir. Immune Defic. Syndr. 58(1):72-79. |
|
|
Zachariah R, Fitzgerald M, Massaquoi M, Pasulani O, Arnould L, Makombe S, Harries A (2006). Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi. AIDS 20:2355-2360. |
|
Copyright © 2025 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
